Volume 70, Issue 6, Pages (December 2016)

Slides:



Advertisements
Similar presentations
The Learning Curve in the Training of Percutaneous Nephrolithotomy
Advertisements

Volume 64, Issue 6, Pages (December 2013)
Volume 70, Issue 6, Pages (December 2016)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis  Maria I. Carlo, Darren R.
Volume 52, Issue 5, Pages (November 2007)
Volume 58, Issue 2, Pages (August 2010)
Volume 55, Issue 3, Pages (March 2009)
The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks  Marcus G.
Evaluation of Proteinuria
Volume 66, Issue 3, Pages (September 2014)
Volume 50, Issue 5, Pages (November 2006)
Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine  Carolyn D. Hurst, Fiona M. Platt, Margaret.
Histologic Grading of Noninvasive Papillary Urothelial Neoplasms
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Let the Games Begin (with EAU Approval)
Volume 64, Issue 3, Pages (September 2013)
Volume 45, Issue 4, Pages (April 2004)
Volume 62, Issue 6, Pages (December 2012)
Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications  Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,
Volume 53, Issue 2, Pages (February 2008)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 59, Issue 3, Pages (March 2011)
Volume 51, Issue 1, Pages (January 2007)
Volume 54, Issue 4, Pages (October 2008)
Volume 61, Issue 5, Pages (May 2012)
Volume 59, Issue 4, Pages (April 2011)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Volume 68, Issue 1, Pages (July 2015)
Volume 63, Issue 5, Pages (May 2013)
Volume 69, Issue 3, Pages (March 2016)
Volume 58, Issue 3, Pages (September 2010)
Volume 64, Issue 3, Pages (September 2013)
Volume 55, Issue 3, Pages (March 2009)
Volume 57, Issue 4, Pages e41-e42 (April 2010)
Volume 56, Issue 6, Pages (December 2009)
James N. Armitage, Stuart O. Irving, Neil A. Burgess  European Urology 
Volume 65, Issue 2, Pages (February 2014)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Validation of Preoperative Nomograms Predicting Lymph Node Involvement in Prostate Cancer: A Bi-institutional Study  Alexander I. Hinev, Vesselin I. Hadjiev,
Volume 66, Issue 6, Pages (December 2014)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update
The Economic Costs of Overactive Bladder in Germany
Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl  European Urology 
Volume 53, Issue 1, Pages (January 2008)
The Learning Curve in the Training of Percutaneous Nephrolithotomy
Volume 54, Issue 6, Pages (December 2008)
Volume 62, Issue 3, Pages (September 2012)
Volume 51, Issue 2, Pages (February 2007)
Volume 50, Issue 5, Pages (November 2006)
Volume 55, Issue 6, Pages (June 2009)
Volume 71, Issue 2, Pages (February 2017)
A Bibliometric Evaluation of Publications in Urological Journals among European Union Countries between 2000–2005  Beibei Oelrich, Robert Peters, Klaus.
Volume 74, Issue 5, Pages (November 2018)
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Volume 54, Issue 6, Pages (December 2008)
European Urology is “Your” Journal
Volume 54, Issue 5, Pages (November 2008)
Volume 51, Issue 5, Pages (May 2007)
Volume 52, Issue 6, Pages (December 2007)
Volume 52, Issue 4, Pages (October 2007)
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Usefulness of a quantitative real-time PCR assay using serum samples to discriminate between inactive, serologically positive and active human brucellosis 
Volume 74, Issue 6, Pages (December 2018)
Volume 54, Issue 3, Pages (September 2008)
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 70, Issue 6, Pages 916-919 (December 2016) A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria  Christina M. Dahmcke, Kenneth E. Steven, Louise K. Larsen, Asger L. Poulsen, Ahmad Abdul-Al, Christina Dahl, Per Guldberg  European Urology  Volume 70, Issue 6, Pages 916-919 (December 2016) DOI: 10.1016/j.eururo.2016.06.035 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 Patient flow chart showing the results of the clinical evaluation. CT=computed tomography; TUR=transurethral resection. European Urology 2016 70, 916-919DOI: (10.1016/j.eururo.2016.06.035) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 2 Performance of the urine-based DNA test for the detection of urothelial bladder carcinoma. (A) Sensitivity and specificity of the test when applied to precystoscopy samples, postcystoscopy samples, and the two combined. Error bars represent 95% confidence intervals (95% CI). (B) Receiver operating characteristic curves for the test. The area under the curve (AUC) was calculated with the corresponding 95% CI. The diagonal line represents a random chance classifier. European Urology 2016 70, 916-919DOI: (10.1016/j.eururo.2016.06.035) Copyright © 2016 European Association of Urology Terms and Conditions